Clinical Features and Predictive Risk Factors for Prognosis in Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis. [PDF]
PM patients exhibit distinctions from IPA in certain clinical characteristics, laboratory parameters, and chest radiology findings. Nevertheless, both PM and IPA patients experienced higher 30‐day mortality and ICU utilization. The combination of NLR and HbA1c with existing disease assessment tools proves effective in prognosticating the disease ...
Bai Y +5 more
europepmc +2 more sources
Comparative Prognosis of Fungal Balls Versus Invasive Pulmonary Mucormycosis [PDF]
Jiayu Wang,1– 4 Naishu Xie,1– 4 Rui Zhao,1– 4 Huihui Zeng,1– 4 Yan Chen1– 4 1Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Research Unit of ...
Wang J, Xie N, Zhao R, Zeng H, Chen Y
doaj +2 more sources
Pulmonary mucormycosis: A case report
Mucormycosis is a rare fungal infection caused by Mucorales order fungi. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas, pulmonary mucormycosis is a rare manifestation in patients with ...
António Grilo Novais +9 more
doaj +3 more sources
Transcriptomic and proteomic profiling of pulmonary mucormycosis reveals a failed activation of host immune response [PDF]
IntroductionMucormycosis is one of the most life-threatening fungal infections with delayed diagnosis and limited antifungal treatments. The transcriptome and proteome of pulmonary mucormycosis have not been fully investigated.MethodsWe obtained lung ...
Jinjin Zhong +10 more
doaj +2 more sources
Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis. [PDF]
BackgroundPulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes.
Junjun Wan +3 more
doaj +2 more sources
Case Report: Pulmonary mucormycosis caused by Rhizopus microsporus in a patient with chronic obstructive pulmonary disease [PDF]
BackgroundWe report a rare case of pulmonary mucormycosis caused by Rhizopus microsporus, which is rare in patients with chronic obstructive pulmonary disease.
Shanshan Wang +4 more
doaj +2 more sources
Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]
Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman +3 more
doaj +1 more source
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
Background Mucormycosis is a rare fungal infection occurring chiefly in the lung or the rhino-orbital-cerebral compartment, particularly in patients with immunodeficiency or diabetes mellitus. Among Mucorales fungi, Rhizopus spp.
F. Yuan +5 more
doaj +1 more source
Isolated pulmonary mucormycosis [PDF]
An obese woman aged 70 years with a history of chronic persistent asthma and diabetes mellitus presented with acute exacerbation and respiratory failure. A chest X-ray and CT scan revealed patchy infiltrates on the right lung along with right hilar and upper lobe masses suggestive of malignancy (figure 1).
Raj Kumar, Mani +3 more
openaire +2 more sources
A rare case of an immunocompetent patient with isolated pulmonary mucormycosis
As one of the most lethal infections caused by fungi, pulmonary mucormycosis usually affects patients who are immunocompromised. Isolated pulmonary mucormycosis in immunocompetent patients is very rare.This report describes a 65-year-old immunocompetent ...
Hamidreza Rouientan +3 more
doaj +1 more source

